Verdient Science

Verdient Science is an active pharmacology consulting firm specializing in clinical and translational pharmacology. They provide services such as clinical protocol design, PK/PD analysis, regulatory support for FDA meetings and submissions, and mathematical modeling for preclinical to human data translation. Their expertise spans neuroscience, oncology, immunology, cannabinoids (including Schedule I substances), psychedelics research, and more. In 2023–2024 they contributed to publications on psychedelic safety and cannabinoid pharmacokinetics; supported Phase 2b/3 study designs for oncology products; performed PK/PD analyses for gene therapies; participated in FDA meetings; and presented at major scientific conferences.